Safe injection, infusion, medication vial, and point-of-care testing practices in healthcare (2025)

Authors

Jennifer Ormsby, Boston Children's Hospital Infection Prevention & Control, 300 Longwood Ave, Boston, MA 02115. Electronic address: jennifer.ormsby@childrens.harvard.edu.
Tonya Wagner, Regent Surgical Health Infection Prevention, 672 Lakeside Drive Moncks Corner, South Carolina 29461. Electronic address: tonyakayewagner@yahoo.com.
Ria Gupta, APIC Program Manager, Center for Research, Practice, and Innovation,1400 Crystal Drive, Suite 900, Arlington, VA 22202. Electronic address: rgupta@apic.org.
Tara Millson, Medstar Georgetown University Hospital Infection Prevention, 3800 Reservoir Rd NW, Washington, D.C. 20007. Electronic address: Tara.K.Millson@medstar.net.
Bethany Phillips, Advocate Health - MidwestFollow

Recommended Citation

Ormsby J, Wagner T, Gupta R, Millson T, Phillips B. Safe Injection, Infusion, Medication Vial, and Point-of-Care Testing Practices in Healthcare (2025). Am J Infect Control. Published online May 12, 2025. doi:10.1016/j.ajic.2025.05.001

Affiliations

Advocate Health Infection Prevention, Oak Brook

Abstract

This position paper provides healthcare professionals (HCP) updated guidance with corresponding evidence and rationale to support safe injection, infusion, medication vial, and point-of-care testing practices in healthcare settings. It addresses the infection risks associated with these practices but does not address other safety issues such as right dose, right site, right medication, phlebotomy, or intravenous catheter care. This document updates the Association for Professionals in Infection Control and Epidemiology (APIC) 2016 position paper.

Document Type

Article

PubMed ID

40368281